Annual EBITDA
-$113.00 K
+$4.77 M+97.69%
December 31, 2023
Summary
- As of February 7, 2025, CDT annual EBITDA is -$113.00 thousand, with the most recent change of +$4.77 million (+97.69%) on December 31, 2023.
- During the last 3 years, CDT annual EBITDA has risen by +$3.06 million (+96.44%).
- CDT annual EBITDA is now at all-time high.
Performance
CDT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$6.29 M
-$1.03 M-19.57%
September 29, 2024
Summary
- As of February 7, 2025, CDT quarterly EBITDA is -$6.29 million, with the most recent change of -$1.03 million (-19.57%) on September 29, 2024.
- Over the past year, CDT quarterly EBITDA has dropped by -$8.92 million (-339.77%).
- CDT quarterly EBITDA is now -339.77% below its all-time high of $2.63 million, reached on September 30, 2023.
Performance
CDT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$14.41 M
-$8.92 M-162.43%
September 29, 2024
Summary
- As of February 7, 2025, CDT TTM EBITDA is -$14.41 million, with the most recent change of -$8.92 million (-162.43%) on September 29, 2024.
- Over the past year, CDT TTM EBITDA has dropped by -$10.60 million (-278.12%).
- CDT TTM EBITDA is now -8962.89% below its all-time high of -$159.00 thousand, reached on December 31, 2023.
Performance
CDT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CDT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +97.7% | -339.8% | -278.1% |
| 3 y3 years | +96.4% | -339.8% | -278.1% |
| 5 y5 years | +96.4% | -339.8% | -278.1% |
CDT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +97.7% | -339.8% | at low | -8962.9% | at low |
| 5 y | 5-year | at high | +97.7% | -339.8% | at low | -8962.9% | at low |
| alltime | all time | at high | +97.7% | -339.8% | at low | -8962.9% | at low |
Conduit Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.29 M(+19.6%) | -$14.41 M(+162.4%) |
| Jun 2024 | - | -$5.26 M(+53.3%) | -$5.49 M(+186.0%) |
| Mar 2024 | - | -$3.43 M(-690.9%) | -$1.92 M(+1107.5%) |
| Dec 2023 | -$113.00 K | $581.00 K(-77.9%) | -$159.00 K(-95.8%) |
| Sep 2023 | - | $2.63 M(-255.1%) | -$3.81 M(-48.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$1.69 M(+1.3%) | -$7.39 M(+29.7%) |
| Mar 2023 | - | -$1.67 M(-45.6%) | -$5.70 M(+31.5%) |
| Dec 2022 | -$4.89 M(+54.0%) | -$3.07 M(+221.2%) | -$4.33 M(+243.2%) |
| Sep 2022 | - | -$956.00 K(+211.4%) | -$1.26 M(+311.4%) |
| Mar 2022 | - | -$307.00 K | -$307.00 K |
| Dec 2021 | -$3.17 M | - | - |
FAQ
- What is Conduit Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals annual EBITDA year-on-year change?
- What is Conduit Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Conduit Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals TTM EBITDA year-on-year change?
What is Conduit Pharmaceuticals annual EBITDA?
The current annual EBITDA of CDT is -$113.00 K
What is the all time high annual EBITDA for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high annual EBITDA is -$113.00 K
What is Conduit Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, CDT annual EBITDA has changed by +$4.77 M (+97.69%)
What is Conduit Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of CDT is -$6.29 M
What is the all time high quarterly EBITDA for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high quarterly EBITDA is $2.63 M
What is Conduit Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, CDT quarterly EBITDA has changed by -$8.92 M (-339.77%)
What is Conduit Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of CDT is -$14.41 M
What is the all time high TTM EBITDA for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high TTM EBITDA is -$159.00 K
What is Conduit Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, CDT TTM EBITDA has changed by -$10.60 M (-278.12%)